These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16415184)

  • 1. B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?
    Anderson M
    Heart; 2006 Feb; 92(2):147-8. PubMed ID: 16415184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.
    Klingenberg R; Zugck C; Becker R; Schellberg D; Heinze G; Kell R; Remppis A; Schoels W; Katus HA; Dengler TJ
    Heart; 2006 Sep; 92(9):1323-4. PubMed ID: 16908708
    [No Abstract]   [Full Text] [Related]  

  • 3. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.
    Christ M; Sharkova J; Bayrakcioglu S; Herzum I; Mueller C; Grimm W
    Eur J Heart Fail; 2007 Mar; 9(3):272-9. PubMed ID: 17027335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.
    Arnaldo FJ; Anatoliotakis N; Palacio C; Nabert DR; Hsu SS
    Heart Lung; 2009; 38(1):10-6. PubMed ID: 19150526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F; Kuschyk J; Veltmann C; Ratay D; Schoene N; Streitner I; Brueckmann M; Schumacher B; Borggrefe M; Wolpert C
    Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers.
    Kanoupakis EM; Manios EG; Vardas PE
    Europace; 2009 Nov; 11(11):1434-9. PubMed ID: 19801563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain natriuretic peptide as a predictor of sudden cardiac death in patients with myocardial infarction.
    Rashidi A; Adler DS
    J Am Coll Cardiol; 2004 Oct; 44(7):1528-9; author reply 1529. PubMed ID: 15464343
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B type natriuretic peptide--a diagnostic breakthrough in peri-operative cardiac risk assessment?
    Rodseth RN
    Anaesthesia; 2009 Feb; 64(2):165-78. PubMed ID: 19143695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children.
    Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S
    Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.
    Godkar D; Bachu K; Dave B; Niranjan S; Khanna A
    Am J Ther; 2008; 15(2):150-6. PubMed ID: 18356635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide: a universal cardiac biomarker?
    Teodorovich N; Krakover R; Vered Z
    Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.